Streetbeat News

Price Targets

STZ

Barclays analyst Lauren Lieberman maintains an Overweight rating on Constellation Brands (NYSE:STZ) but lowers the price target from $309 to $300.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:20 pm

COIN

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on Coinbase Global (NASDAQ:COIN) and raises the price target from $169 to $175.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:19 pm

TW

Barclays analyst Benjamin Budish has maintained an Overweight rating on Tradeweb Markets (NASDAQ:TW) and increased the price target from $125 to $147.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:17 pm

CG

Barclays analyst Benjamin Budish maintains an Overweight rating on Carlyle Group and raises the price target from $46 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:06 pm

STEP

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on StepStone Group (NASDAQ:STEP) and raises the price target from $51 to $61.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:05 pm

HOOD

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on Robinhood Markets (NASDAQ:HOOD) and raises the price target from $20 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:03 pm

PX

Barclays analyst Benjamin Budish maintains an Overweight rating on P10 (NYSE:PX) and raises the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:01 pm

MRX

Marex Group (NASDAQ:MRX) has been analyzed by four analysts, showing a somewhat bullish sentiment with an average 12-month price target of $28.75, up from $26.75. Analysts from Barclays and Piper Sandler have raised their price targets, indicating positive expectations. Despite this, Marex Group faces challenges with below-average net margins and high debt-to-equity ratios.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 7:00 pm

VRNS

Varonis Systems (NASDAQ:VRNS) has received mixed analyst ratings, with a majority being somewhat bullish. Recent analyst actions include several rating upgrades and increased price targets, reflecting positive sentiment. The average 12-month price target is $59.77, up from $54.92. Despite positive revenue growth, Varonis faces challenges with profitability and returns, as indicated by below-average net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 7:00 pm

NDAQ

Barclays analyst Benjamin Budish has maintained an Overweight rating on Nasdaq (NDAQ) and raised the price target from $77 to $84.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 7:00 pm